Market News & Trends
Opsonix is Launched to Develop Pathogen-Extracting Therapy
Opsonix, Inc. recently announced the company’s launch with an $8-million Series A financing to develop a pathogen-extracting therapy designed to remove infectious pathogens and toxins…
Codexis Earns $6.5-Million Milestone From GSK
Codexis, Inc. recently announced it successfully completed Wave 2 of the transfer of its proprietary CodeEvolver protein engineering platform technology to GlaxoSmithKline (GSK) in the…
Emisphere Signs Lucrative License Agreement With Novo Nordisk
Emisphere Technologies, Inc. recently announced it has entered into a Development and License Agreement with Novo Nordisk A/S to develop and commercialize oral formulations of…
West Launches New Ready-to-Use/Validated Components
West Pharmaceutical Services, Inc. recently launched Daikyo RUV (ready-to-use/validated) components at CPhI Worldwide/InnoPack Europe 2015 in Madrid, Spain. In addition, West is showcasing a range…
Ajinomoto Althea Expands Manufacturing Capabilities to ADC Fill Finish & Bioconjugation
Ajinomoto Althea, Inc. recently announced it is expanding its existing biological drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates…
Zealand Meets Development Milestone in Collaboration With Boehringer Ingelheim
Zealand recently announced that Boehringer Ingelheim has selected a novel peptide therapeutic to be advanced into preclinical development under one of two ongoing collaboration agreements…
Ergomed Significantly Increases Contribution in CEL-SCI’s Phase III Trial
CEL-SCI Corporation and its Clinical Research Organization (CRO) Ergomed plc recently announced they have expanded their co-development agreement with increased activities to be undertaken by…
Enable Injections Introduces Mobile Monitoring & Larger Volume Capabilities to its Wearable Injectors
Enable Injections, the developer and manufacturer of a new wearable injector technology platform that allows patients to comfortably and easily self-administer large volume drugs subcutaneously,…
Capsugel Expands Its Successful DRcaps Capsule Platform With New Liquid-Fill Capability
Capsugel recently announced it has developed a technology that makes its vegetarian, acid-resistant DRcaps hard capsules suitable for liquid-fill applications. As a result, Capsugel’s customers…
Baxalta & Momenta Announce Initiation of Pivotal Clinical Trial for Biosimilar
Baxalta Incorporated and Momenta Pharmaceuticals, Inc. recently announced the initiation of a pivotal clinical trial in patients with chronic plaque psoriasis for M923, a biosimilar…